Adicet Bio
ACET
ACET
54 hedge funds and large institutions have $26.8M invested in Adicet Bio in 2019 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 9 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
11% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 18
84% less capital invested
Capital invested by funds: $169M → $26.8M (-$142M)
Holders
54
Holding in Top 10
–
Calls
$28K
Puts
$21K
Top Buyers
| 1 | +$5.25M | |
| 2 | +$2.14M | |
| 3 | +$1.09M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$907K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$683K |
Top Sellers
| 1 | -$38.2M | |
| 2 | -$23.3M | |
| 3 | -$6.65M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$4.42M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$3.54M |